The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D002994:Clofibrate / Q000494:pharmacology; D003864:Depression, Chemical; D005260:Female; D000882:Haplorhini; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008253:Macaca mulatta; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D013997:Time Factors; D014280:Triglycerides / Q000096:biosynthesis / Q000097:blood; D014631:Valerates / Q000494:pharmacology* / Q000627:therapeutic use; D014992:Xylenes / Q000494:pharmacology* / Q000627:therapeutic use
D000960:Hypolipidemic Agents; D008055:Lipids; D014280:Triglycerides; D014631:Valerates; D014992:Xylenes; D002784:Cholesterol; D002994:Clofibrate